• Carbon

    -
  • Waste

    -
  • Water

    -
  • Energy

    -
  • Revenue

    3,481 Million USD
Rank 22
Rank 24
Rank
4507-TO
JP3347200002
JAPAN
Health Care
Pharmaceuticals

About Company

Shionogi & Company, Limited (TYO: 4507, OSE: 4507) is a Japanese pharmaceutical company best known for developing Crestor. Medical supply and brand name also uses Shionogi

The company engages in the manufacture and sale of pharmaceuticals. The Company operates in two business segments. The Pharmaceutical and Related Business segment is engaged in the development, manufacturing and sale of general pharmaceuticals and diagnostic drugs, including vitamin preparations, antipyretics and analgesics, eye care products, cold and sinus medicine, digestive medicine, dermatologic preparations, test paper for glucose in urine and artificial teeth-related products. The Others segment is engaged in the leasing of real estate and the provision of logistics services. As of March 31, 2010, the Company had 17 consolidated subsidiaries and four associated companies.

The company has teamed up with US based Schering-Plough to become a sole marketing agent for its products in Japan.Shionogi had also supported the initial formation of Ranbaxy Pharmaceuticals, a generic manufacturer based in India.

Company Website: www.shionogi.co.jp
Corporate Responsibility Website: Environmental Activities at Shionogi

Subscribe to the
Justmeans ESG Dashboard

A subscription includes full access to Environmental, Social, and Governance Data, company comparisons, ability to share data charts, custom reports, and more.

Learn more...